Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.

Gleixner, K V; Mayerhofer, M; Vales, A; Gruze, A; Hörmann, G; Cerny-Reiterer, S; Lackner, E; Hadzijusufovic, E; Herrmann, H; Iyer, A K; Krauth, M-T; Pickl, W F; Marian, B; Panzer-Grümayer, R; Sillaber, C; Maeda, H; Zielinski, C; Valent, P

Gleixner, K V; Mayerhofer, M; Vales, A; Gruze, A; Hörmann, G; Cerny-Reiterer, S; Lackner, E; Hadzijusufovic, E; Herrmann, H; Iyer, A K; Krauth, M-T; Pickl, W F; Marian, B; Panzer-Grümayer, R; Sillaber, C; Maeda, H; Zielinski, C; Valent, P.

Affiliation

Gleixner KV; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, A-1090 Vienna, Austria.

Curr Cancer Drug Targets ; 9(5): 675-89, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19508170

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polystyrenes / Leukemia / Heme Oxygenase-1 / Maleates / Metalloporphyrins / Neoplasms / Antineoplastic Agents Limits: Female / Humans Language: En Journal: Curr Cancer Drug Targets Journal subject: ANTINEOPLASICOS / NEOPLASIAS Year: 2009 Document type: Article Affiliation country: Country of publication:

Search on Google

Add to My VHL

XML

PubMed Links